Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years- JATENZO is an oral softgel testosterone undecanoate for testosterone ...
RALEIGH, N.C., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that KYZATREX ® (testosterone undecanoate) CIII capsules will be highlighted in three research abstracts ...
TORONTO—Testosterone undecanoate administered every three months is a safe treatment for hypogonadal men, according to a four-year study. Parenteral testosterone undecanoate (TU) was administered to ...
NORTHBROOK, Ill., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today announced that Express Scripts, Inc, one of the leading pharmacy benefit managers (PBMs) in the United States will ...
Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. Science X Daily ...
RALEIGH, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Gameday Men's Health, the leader in men's health clinics nationwide, today announced it is expanding its testosterone therapy options to include ...
Tlando is supplied as 112.5mg of testosterone undecanoate capsules. Tlando ™ (testosterone undecanoate) is now available for testosterone replacement therapy in adult males for conditions associated ...
RALEIGH, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today ...
Long-term treatment with testosterone undecanoate was associated with reduced cardiovascular morbidity and mortality in patients with hypogonadism and type 2 diabetes. SAN FRANCISCO — Long-term ...
Apotex and Grünenthal have finalised a licensing agreement granting Apotex exclusive Canadian rights to Nebido, a long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results